AAAAAA

   
Results: 1-21 |
Results: 21

Authors: Sodhi, MS Burnet, PWJ Makoff, AJ Kerwin, RW Harrison, PJ
Citation: Ms. Sodhi et al., RNA editing of the 5-HT2C receptor is reduced in schizophrenia, MOL PSYCHI, 6(4), 2001, pp. 373-379

Authors: Arranz, MJ Mancama, D Kerwin, RW
Citation: Mj. Arranz et al., Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review), INT J MOL M, 7(1), 2001, pp. 27-30

Authors: Collier, DA Osborne, S Munro, J Kerwin, RW
Citation: Da. Collier et al., Pharmacogenetic methods in schizophrenia, INT R PSYC, 13(1), 2001, pp. 47-49

Authors: Bolonna, AA Kerwin, RW Munro, J Arranz, MJ Makoff, AJ
Citation: Aa. Bolonna et al., Polymorphisms in the genes for mGluR types 7 and 8: association studies with schizophrenia, SCHIZOPHR R, 47(1), 2001, pp. 99-103

Authors: Pariante, CM Makoff, A Lovestone, S Feroli, S Heyden, A Miller, AH Kerwin, RW
Citation: Cm. Pariante et al., Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters, BR J PHARM, 134(6), 2001, pp. 1335-1343

Authors: Bigliani, V Mulligan, RS Acton, PD Ohlsen, RI Pike, VW Ell, PJ Gacinovic, S Kerwin, RW Pilowsky, LS
Citation: V. Bigliani et al., Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [I-123]epidepride single photon emission tomography (SPET) study, PSYCHOPHAR, 150(2), 2000, pp. 132-140

Authors: Arranz, MJ Bolonna, AA Munro, J Curtis, CJ Collier, DA Kerwin, RW
Citation: Mj. Arranz et al., The serotonin transporter and clozapine response, MOL PSYCHI, 5(2), 2000, pp. 124-125

Authors: Aitchison, KJ Gonzalez, FJ Quattrochi, LC Sapone, A Zhao, JH Zaher, H Elizondo, G Bryant, C Munro, J Collier, DA Makoff, AJ Kerwin, RW
Citation: Kj. Aitchison et al., Identification of novel polymorphisms in the 5 ' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance, PHARMACOGEN, 10(8), 2000, pp. 695-704

Authors: Birkett, JT Arranz, MJ Munro, J Osbourn, S Kerwin, RW Collier, DA
Citation: Jt. Birkett et al., Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response, NEUROREPORT, 11(9), 2000, pp. 2017-2020

Authors: Arranz, MJ Kerwin, RW
Citation: Mj. Arranz et Rw. Kerwin, Neurotransmitter-related genes and antipsychotic response: pharmacogenetics meets psychiatric treatment, ANN MED, 32(2), 2000, pp. 128-133

Authors: Bolonna, AA Arranz, MJ Munro, J Osborne, S Petouni, M Martinez, M Kerwin, RW
Citation: Aa. Bolonna et al., No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response, NEUROSCI L, 280(1), 2000, pp. 65-68

Authors: Aitchison, KJ Jann, MW Zhao, JH Sakai, T Zaher, H Wolff, K Collier, DA Kerwin, RW Gonzalez, FJ
Citation: Kj. Aitchison et al., Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice, J PSYCHOPH, 14(4), 2000, pp. 353-359

Authors: Bell, R Munro, J Russ, C Powell, JF Bruinvels, A Kerwin, RW Collier, DA
Citation: R. Bell et al., Systematic screening of the 14-3-3 eta (eta) chain gene for polymorphic variants and case-control analysis in schizophrenia, AM J MED G, 96(6), 2000, pp. 736-743

Authors: Lingford-Hughes, AR Acton, PD Gacinovic, S Boddington, SJA Costa, DC Pilowsky, LS Ell, PJ Marshall, EJ Kerwin, RW
Citation: Ar. Lingford-hughes et al., Levels of gamma-aminobutyric acid-benzodiazepine receptors in abstinent, alcohol-dependent women: Preliminary findings from an I-123-iomazenil singlephoton emission tomography study, ALC CLIN EX, 24(9), 2000, pp. 1449-1455

Authors: Arranz, MJ Munro, J Osborne, S Collier, D Kerwin, RW
Citation: Mj. Arranz et al., Difficulties in replication of results, LANCET, 356(9238), 2000, pp. 1359-1360

Authors: Arranz, MJ Munro, J Birkett, J Bolonna, A Mancama, D Sodhi, M Lesch, KP Meyer, JFW Sham, P Collier, DA Murray, RM Kerwin, RW
Citation: Mj. Arranz et al., Pharmacogenetic prediction of clozapine response, LANCET, 355(9215), 2000, pp. 1615-1616

Authors: Stephenson, CME Bigliani, V Jones, HM Mulligan, RS Acton, PD Visvikis, D Ell, PJ Kerwin, RW Pilowsky, LS
Citation: Cme. Stephenson et al., Striatal and extra-striatal D-2/D-3 dopamine receptor occupancy by quetiapine in vivo - [I-123]-epidepride single photon emission tomography (SPET) study, BR J PSYCHI, 177, 2000, pp. 408-415

Authors: Jones, HM Travis, MJ Mulligan, R Visvikis, D Gacinovic, S Ell, PJ Kerwin, RW Pilowsky, LS
Citation: Hm. Jones et al., In vivo serotonin 5-HT2A receptor occupancy and quetiapine, AM J PSYCHI, 157(1), 2000, pp. 148-148

Authors: Aitchison, KJ Munro, J Wright, P Smith, S Makoff, AJ Sachse, C Sham, PC Murray, RM Collier, DA Kerwin, RW
Citation: Kj. Aitchison et al., Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation, BR J CL PH, 48(3), 1999, pp. 388-394

Authors: Bigliani, V Mulligan, RS Acton, PD Visvikis, D Ell, PJ Stephenson, C Kerwin, RW Pilowsky, LS
Citation: V. Bigliani et al., In vivo occupancy of striatal and temporal cortical D-2/D-3 dopamine receptors by typical antipsychotic drugs - [I-123]-epidepride single photon emission tomography (SPET) study, BR J PSYCHI, 175, 1999, pp. 231-238

Authors: Arranz, MJ Li, T Munro, J Liu, X Murray, R Collier, DA Kerwin, RW
Citation: Mj. Arranz et al., Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response, PHARMACOGEN, 8(6), 1998, pp. 481-484
Risultati: 1-21 |